This Supreme Court decision allows for the patenting of living organisms, which had been forbidden prior to this decision. From the filing: In 1972, respondent [Ananda M.] Chakrabarty, a microbiologist, filed a patent application, assigned to the General Electric Co. The application asserted 36 claims related to Chakrabarty’s invention of “a bacterium from the genus…
A process is described for preparing adrenochrome comprising oxidizing adrenaline or a salt thereof with a persulfate in an aqueous medium at a pH in the range 4 to 8 in the presence of one or more water-soluble salts of bismuth. — Process for preparing adrenochrome Source:
A paralytic peptide, ψ-conotoxin Piiie has been purified and characterized from Conus purpurascens venom. Electrophysiological studies indicate that the peptide inhibits the nicotinic acetylcholine receptor (nAChR). However, the peptide does not block the binding of α-bungarotoxin, a competitive nAChR antagonist. Thus, ψ-conotoxin Piiie appears to inhibit the receptor at a site other than the acetylcholine-binding site. As ascertained by…
From the patent: The present invention provides the amino acid and nucleotide sequences of a CCV spike gene, and compositions containing one or more fragments of the spike gene and encoded polypeptide for prophylaxis, diagnostic purposes and treatment of CCV infections. — Patent US6372224B1 This is the patent for the spike protein virus, a vaccine…
Physiological effects have been observed in a human subject in response to stimulation of the skin with weak electromagnetic fields that are pulsed with certain frequencies near ½ Hz or 2.4 Hz, such as to excite a sensory resonance. Many computer monitors and TV tubes, when displaying pulsed images, emit pulsed electromagnetic fields of sufficient…
A helper cell for producing an infectious, replication defective, coronavirus (or more generally nidovirus) particle cell comprises (a) a nidovirus permissive cell; (b) a nidovirus replicon RNA comprising the nidovirus packaging signal and a heterologous RNA sequence, wherein the replicon RNA further lacks a sequence encoding at least one nidovirus structural protein; and (c) at…
Disclosed herein is a newly isolated human coronavirus (SARS-CoV), the causative agent of severe acute respiratory syndrome (SARS). Also provided are the nucleic acid sequence of the SARS-CoV genome and the amino acid sequences of the SARS-CoV open reading frames, as well as methods of using these molecules to detect a SARS-CoV and detect infections…
The invention provides compositions and methods that are useful for preventing and treating a coronavirus infection in a subject. More specifically, the invention provides peptides and conjugates and pharmaceutical compositions containing those peptides and conjugates that block fusion of a coronavirus, such as the SARS virus, to a target cell. This blocking mechanism prevents or…
Disclosed herein is a newly isolated human coronavirus (SARS-CoV), the causative agent of severe acute respiratory syndrome (SARS). Also provided are the nucleic acid sequence of the SARS-CoV genome and the amino acid sequences of the SARS-CoV open reading frames, as well as methods of using these molecules to detect a SARS-CoV and detect infections…
The present invention relates in part to amino acid sequences that are directed against and/or that can specifically bind to an envelope protein of a virus, as well as to compounds or constructs, and in particular proteins and polypeptides, that comprise or essentially consist of one or more such amino acid sequences. — Patent US9193780B2…
The present disclosure is directed in part to a biocompatible nanoparticle composition comprising a plurality of non-colloidal long circulating nanoparticles, each comprising a α-hydroxy polyester-co-polyether and a therapeutic agent, wherein such disclosed compositions provide a therapeutic effect for at least 12 hours. — Patent US20100216804A1 “As you read through a patent, what you’ll find,…
A composite magnetic nanoparticle drug delivery system provides targeted controlled release chemotherapies for cancerous tumors and inflammatory diseases. The magnetic nanoparticle includes a biocompatible and biodegradable polymer, a magnetic nanoparticle, the biological targeting agent human serum albumin, and a therapeutic pharmaceutical composition. The composite nanoparticles are prepared by oil-in-oil emulsion/solvent evaporation and high shear mixing.…
Botanical compositions comprising non-alcoholic organic extracts of Ganoderma lucidum, Salvia miltiorrhiza, and Scutellaria barbata for use in conjunction with bicalutamide therapy fpr cancer therapy, are provided. Methods for treatment or therapy of prostate cancer in a human is provided, the method comprising: administering an effective amount of a botanical composition that is effective for reducing…
An illustrative method for transferring data to a device includes identifying the data that is to be transferred to the device, modulating the data with a signal, providing the signal to a contact microphone that is in physical contact with an individual, and transmitting the signal through a body of the individual to the device…
Water-dispersible nanoparticles are prepared by applying a coating of a multiply amphipathic dispersant to the surface of a hydrophobic nanoparticle comprised of a semiconductive or metallic material. The multiply amphipathic dispersant has two or more hydrophobic regions and two or more hydrophilic regions, and is typically polymeric. Preferred polymeric dispersants are comprised of (1) a…
A system and method for biometric identification of a target individual based on a query containing UV image data of the target individual. In one embodiment, the system includes a first database, a query module, a detection module, a sequence module and a match module. The first database includes a plurality of identities with each…
A method of retrieving sequence-verified deoxyribonucleic acid (DNA) includes positioning a sequence-verified DNA molecule on a microelectromechanical systems (MEMS) substrate. The MEMS substrate includes an electrostatic actuator and the sequence-verified DNA molecule is positioned adjacent to a moving element. The method also includes applying a voltage between the moving element and a stator to cause…
A method for making semiconducting single walled carbon nanotubes (SWCNTs) includes providing a substrate. A single walled carbon nanotube film including a plurality of metallic SWCNTs and semiconducting SWCNTs is located on the substrate. A macromolecule material layer is located on the single walled carbon nanotube film to cover the single walled carbon nanotube film.…
The present invention provides compositions and systems for delivery of nanocarriers to cells of the immune system. The invention provides vaccine nanocarriers capable of stimulating an immune response in T cells and/or B cells, in some embodiments, comprising at least one immunomodulatory agent, and optionally comprising at last one targeting moiety and optionally at least…
This landmark case pitted cancer survivors and the American Civil Liberties Union against the diagnostic company, Myriad Genetics. Sources: See also, on this site: Attorney updates us on evidence found in a military case Report: mRNA “vaccines” are converted to DNA in the liver
. Nanoparticle delivery systems for use in targeting biologically active agents to the central nervous system comprise a composition comprising (a) a nanoparticle comprising: (i) a core comprising a metal and/or a semiconductor; and (ii) a corona comprising a plurality of ligands covalently linked to the core, wherein said ligands comprise a carbohydrate, insulin and/or…
The present invention generally relates to nanoscale wires and/or injectable devices. In some embodiments, the present invention is directed to electronic devices that can be injected or inserted into soft matter, such as biological tissue or polymeric matrixes. For example, the device may be passed through a syringe or a needle. In some cases, the…
Methods, systems, and products provide interfaces between intrahost networks and interhost networks within biological hosts. Neuroregional translations are performed to route communications to and from the biological hosts. Bioregional translations may also be performed to route communications to and from the biological hosts. — Patent US10163055B2 Source: Local copy. Related: Additional posts citing this video.…
The invention relates to compositions and methods for the preparation, manufacture and therapeutic use of polynucleotides, primary transcripts and mmRNA molecules. — Patent US9828416B2 A pharmaceutical composition which has a plurality of lipid nanoparticles that has a mean particle size of between 80 nm and 160 nm and contains a modified mRNA encoding a polypeptide.…
The present invention provides a live, attenuated coronavirus comprising a variant replicase gene encoding polyproteins comprising a mutation in one or more of non-structural protein(s) (nsp)-10, nsp-14, nsp-15 or nsp-16. The coronavirus may be used as a vaccine for treating and/or preventing a disease, such as infectious bronchitis, in a subject. — Patent US10130701B21 Sources:…
A method is provided for processing and displaying biometric data of a user, either alone or together (in synchronization) with other data, such as video data of the user during a time that the biometric data was acquired. The method includes storing biometric data so that it is linked to an identifier and at least…
Human body activity associated with a task provided to a user may be used in a mining process of a cryptocurrency system. A server may provide a task to a device of a user which is communicatively coupled to the server. A sensor communicatively coupled to or comprised in the device of the user may…
The present disclosure provides methods of producing lipid nanoparticle (LNP) formulations and the produced LNP formulations thereof. The present disclosure also provides therapeutic and diagnostic uses related to the produced LNP formulations. — Patent WO2020160397A1 Sources: See also, on this site: Posts citing Clay Clark with Judy Mikovits in Doctor Judy Mikovits Breaks Down the…
The present invention relates to an injection solution, a physiological saline solution, a glucose solution, and an IV, which are to be administered in a blood vessel and subcutaneous tissue of the human body for the purpose of curing a disease. A physiological saline solution containing graphene dispersed therein according to the present invention and…
A method is provided for acquiring and transmitting biometric data (e.g., vital signs) of a user, where the data is analyzed to determine whether the user is suffering from a viral infection, such as COVID-19. The method includes using a pulse oximeter to acquire at least pulse and blood oxygen saturation percentage, which is transmitted…
The invention belongs to the field of nano materials and biomedicine, and relates to a vaccine, in particular to development of 2019-nCoV coronavirus nuclear recombinant nano vaccine. The invention also comprises a preparation method of the vaccine and application of the vaccine in animal experiments. The new corona vaccine contains graphene oxide, carnosine, CpG and…
This Pfizer patent application was approved August 31st, 2021, and is the very first patent that shows up in a list of over 18500 for the purpose of remote contact tracing of all vaccinated humans worldwide who will be or are now connected to the “internet of things” by a quantum link of pulsating microwave…
The present disclosure relates to the fields of packaging, transportation, and storage of temperature-sensitive materials, such as biological and/or pharmaceutical products. Various aspects of such packaging, transportation, and storage are provided herein for ultra-low temperature materials useful for the treatment and/or prevention of disease. The present disclosure also provides packaging materials, methods of transportation, and…
A method is provided for acquiring and transmitting biometric data (e.g., vital signs) of a user, where the data is analyzed to determine whether the user is suffering from a viral infection, such as COVID-19. The method includes using a pulse oximeter to acquire at least pulse and blood oxygen saturation percentage, which is transmitted…
The interview cited below was conducted as part of the Stiftung Corona Ausschuss project that is expected to result in a “Nuremberg 2” trial. Reiner Fuellmich is a lawyer for the Stiftung Corona Ausschuss project, and so this could be considered to be a deposition hearing. As Gary D. Barnett said, This recent interview between Dr. David…
In my latest interview with Stew Peter’s, we discussed how the “Covid-19 vaccine” ingredients listed in the patents, reveal that all these poisonous death shots are deleting genes and genetically modifying Humans for patentability. I can vouch for the fact that these companies seek to patent humans. I once knew someone who was using an experimental treatment for cancer. …
Complaints to be filed in both United States and Germany alleging that Pfizer and BioNTech’s COVID-19 vaccine Comirnaty® unlawfully infringes patents Moderna filed between 2010 and 2016 Moderna not seeking removal of Comirnaty® from market or injunction against future sales Company not pursuing monetary damages on sales to the 92 low- and middle-income countries in…
Wearable technology has made significant advancements since the introduction of the first fitness trackers and smartwatches. The latest innovation in this field is biosensor earbuds, a new wearable device that promises to revolutionize health monitoring. With the help of advanced sensors, these earbuds can provide real-time health data, enhancing personal healthcare and potentially saving lives.…